| Contact us | |
| Return to database |
Prevalence (%) of clinical parameters based on data from 2 references describing 459 individuals
Add new symptom/sign to this disease
| Pubmed id number as a reference | Organ system affected | ||
| Number of patients in the reference | Percent affected patients (Between 0 and 1, eg. 0.1 = 10%) | ||
| Please provide your name and contact information as a reference | |||
| Name | Institute | Phone number | Email address |
List of symptoms
| Symptom/sign | Organ system | Percent affected | Pubmed id | Added on(yyyy-mm-dd) | Edit/add reference |
| Hypercholesterolemia | circulatory | 100 % | 21663647 | 2012-01-18 | |
| Increased blood LDL | circulatory | 100 % | 2243428 | 2019-01-10 | |
| Xanthomas | integumentary | 21 % | 21663647 | 2012-01-18 | |
| Ischaemic heart disease | circulatory | 20 % | 21663647 | 2012-01-18 | |
| Hypertension | circulatory | 15 % | 21663647 | 2012-01-18 | |
| Diabetes mellitus type 2 | endocrine | 2 % | 21663647 | 2012-01-18 |
List of references:
Clinical characteristics and evaluation of LDL-cholesterol treatment of the Spanish Familial Hypercholesterolemia Longitudinal Cohort Study (SAFEHEART).
Nelva Mata, Rodrigo Alonso, Lina Badimón, Teresa Padró, Francisco Fuentes, Ovidio Muñiz, Francisco Perez-Jiménez, José López-Miranda, Jose L Díaz, Jose I Vidal, A Barba, Mar Piedecausa, Juan F Sanchez, Luis Irigoyen, Eliseo Guallar, José M Ordovas, Pedro Mata,
Lipids in health and disease - Jun 2011
Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens.
J P Kane, M J Malloy, T A Ports, N R Phillips, J C Diehl, R J Havel,
JAMA - Dec 1990